These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20144058)

  • 1. Novel antioxidant technology for prostate cancer chemoprevention and treatment.
    Attia S; Wilding G
    Expert Opin Ther Pat; 2006 Sep; 16(9):1255-67. PubMed ID: 20144058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
    Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
    Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional aspects of prostate cancer: a review.
    Blumenfeld AJ; Fleshner N; Casselman B; Trachtenberg J
    Can J Urol; 2000 Feb; 7(1):927-35; discussion 936. PubMed ID: 11121247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate.
    Clinton SK; Emenhiser C; Schwartz SJ; Bostwick DG; Williams AW; Moore BJ; Erdman JW
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):823-33. PubMed ID: 8896894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
    Hernáandez J; Syed S; Weiss G; Fernandes G; von Merveldt D; Troyer DA; Basler JW; Thompson IM
    J Urol; 2005 Aug; 174(2):519-22. PubMed ID: 16006884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
    Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
    Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Insight: lycopene in the prevention and treatment of prostate cancer.
    Guns ES; Cowell SP
    Nat Clin Pract Urol; 2005 Jan; 2(1):38-43. PubMed ID: 16474575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nutrition and pharmacological treatment for prevention of prostate cancer].
    Segev Y; Nativ O
    Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D in the prevention and treatment of prostate cancer.
    Konety BR; Johnson CS; Trump DL; Getzenberg RH
    Semin Urol Oncol; 1999 May; 17(2):77-84. PubMed ID: 10332920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on chemoprevention strategies in prostate cancer for 2006.
    Neill MG; Fleshner NE
    Curr Opin Urol; 2006 May; 16(3):132-7. PubMed ID: 16679848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E, alpha- and gamma-tocopherol, and prostate cancer.
    Moyad MA; Brumfield SK; Pienta KJ
    Semin Urol Oncol; 1999 May; 17(2):85-90. PubMed ID: 10332921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cells exposed to lycopene in vitro liberate lycopene-enriched exosomes.
    Goyal A; Delves GH; Chopra M; Lwaleed BA; Cooper AJ
    BJU Int; 2006 Oct; 98(4):907-11. PubMed ID: 16978292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
    Pathak SK; Sharma RA; Mellon JK
    Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular chemoprevention by selenium: a genomic approach.
    El-Bayoumy K; Sinha R
    Mutat Res; 2005 Dec; 591(1-2):224-36. PubMed ID: 16099479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycopene in the prevention of prostate cancer.
    Dahan K; Fennal M; Kumar NB
    J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of prostate cancer.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Klein EA
    J Urol; 2009 Aug; 182(2):499-507; discussion 508. PubMed ID: 19524966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.